The University of Chicago received a $785,511 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to develop induced pluripotent stem cell (iPSC)-derived macrophages as a model to study the genetic basis of individual variations in immune responses to pathogens. The award, with a project period from January 2025 to December 2029, will support research aimed at improving understanding of how individual genetic factors contribute to differences in susceptibility and immune system responses to infectious diseases. The Allergy and Infectious Diseases Research program, administered by the National Institutes of Health, funds a broad portfolio of investigative projects focused on addressing complex public health challenges related to infectious agents and immune system function.
Generated 3/4/25, 6:28 AM